Regulation and Risk Assessment of 1,4-Dioxane - Environmental Investigation and Remediation - page 321

Steinman, D., 2007, Safe Trip to Eden: 10 Steps to Save Planet Earth from the Global Warming Meltdown . NY:
Thunder's Mouth Press.
Stickney, J.A., Sager, S.L., Clarkson, J.R., Smith, L.A., Locey, B.J., Bock, M.J., Hartung, R., and Olp, S.F.,
2003, An updated evaluation of the carcinogenic potential of 1,4-dioxane. Regulatory Toxicology and
Pharmacology 38(2003): 183-195.
STM, 2005, HTP-arvot 2005 (Finnish Occupational Exposure Levels) . Helsinki, Finland: Ministry of Social
Affairs and Health.
SWEA, 2005, Occupational exposure limit values and measures against air contaminants. Swedish Work
Environment Authority, Solna, Sweden. www.av.se/dokument/inenglish/legislations/eng0517.pdf (accessed
March 18, 2007).
Tanabe, A., Tsuchida, Y., Ibaraki, T., and Kawata, K., 2006, Impact of 1,4-dioxane from domestic efl uent on the
Agano and Shinano Rivers, Japan. Bulletin of Environmental Contamination and Toxicology 76: 44-51.
Taylor, W.A., Jamriska, D.J., Hamilton, V.T., et al., 1995, Waste minimization in the Los Alamos medical radio-
isotope program. Journal of Radioanalytical and Nuclear Chemistry 195(2): 287-295.
TELL, 1996, Division of Solid Waste Management revises remediation guidance levels. Tennessee Environmental
Law Letter 8(2): 15-21.
Thomulka, K.W. and McGee, D.J., 1992, Evaluation of organic compounds in water using Photobacterium
phosphoreum and Vibrio harveyi bioassays. Fresenius Environmental Bulletin 1: 815-820.
Torkelson, R., Leong, B.K.J., Kociba, R.J., Richter, W.A., and Gehring, P.J., 1974, 1,4 Dioxane. II. Results of
a 2-year inhalation study in rats. Toxicology and Applied Pharmacology 30: 287-298.
TOSC, 2007, Michigan's Department of Environmental Quality (DEQ) decision concerning 1,4-dioxane.
Technical Outreach Services for Communities Program. http://www.egr.msu.edu/tosc/gelman/1,4-diox-
ane_contaminant_level.doc (accessed December 28, 2007).
Toshinari, S., Tsuyoshi, I., Mihoko, U., Kazuo, Y., and Kumiko, Y., 2005, Monitoring of 1,4-dioxane in ground-
water and river water at the Tama District in Tokyo. Journal of Japan Society on Water Environment
28(2): 139-143.
Tucson Water, 2004, 2003 Annual water quality report. Water Quality Management Division.
UCB, 2006, The carcinogenic potency database [Lois Swirsky Gold, Ph.D., Director, University of California,
Berkeley]. http://potency.berkeley.edu/ (accessed November 6, 2006).
UKH SE, 2007, EH/40 Occupational Exposure Limits, United Kingdom Health & Safety Executive. http://
www.hse.gov.uk/coshh/table1.pdf (accessed November 17, 2007).
U.S. Army, 2000, Standard practice for wildlife toxicity reference values. U.S. Army Center for Health
Promotion and Preventive Medicine.
U.S. Congress, 1987, Identifying and regulating carcinogens. Washington, DC: Ofi ce of Technology
Assessment, U.S. Government Printing Ofi ce.
U.S. Court of Appeals for the Sixth Circuit, 1984, Scott v. Food and Drug Administration, 728 F. 2d 322 (6th
Cir. 1984), Dept. of Justice, Antitrust Division, Washington, D.C. http://www.altlaw.org/v1/cases/495895
(accessed November 15, 2008).
U.S. Environmental Protection Agency (USEPA), 1986, Guidelines for carcinogen risk assessment. U.S.
Environmental Protection Agency 51: 38,992-34,003.
U.S. Environmental Protection Agency (USEPA), 1988, National Sewage Sludge Survey. NTIS: PB93-500403.
U.S. Environmental Protection Agency (USEPA), 1992a, Dermal exposure assessment: Principles and applica-
tions. U.S. Environmental Protection Agency, Ofi ce of Health and Environmental Assessment.
U.S. Environmental Protection Agency (USEPA), 1992b, Draft report: A cross-species scaling factor for carcino-
gen risk assessment based on equivalence of mg/kg 3/4 /Day. Federal Register 57(409): 24,152-24,173.
U.S. Environmental Protection Agency (USEPA), 1996a, 40 CFR Part 131, proposed guidelines for carcinogen
risk assessment. Federal Register 61: 17,959-18,011.
U.S. Environmental Protection Agency (USEPA), 1996b, ASTER database. U.S. Environmental Protection
Agency, National Health and Environmental Effects Research Laboratory.
U.S. Environmental Protection Agency (USEPA), 1997a, Proi le of the pharmaceutical manufacturing industry.
U.S. Environmental Protection Agency, Ofi ce of Enforcement and Compliance Assurance.
U.S. Environmental Protection Agency (USEPA), 1997b, Notice of availability; efl uent limitations guidelines,
pretreatment standards, and new source performance standards: Pharmaceutical manufacturing
category—40 CFR part 439. Federal Register 62(153): 42,720-42,732.
U.S. Environmental Protection Agency (USEPA), 1998a, Development document for i nal efl uent limitations
guidelines and standards for the pharmaceutical manufacturing point source category. U.S. Environmental
Protection Agency, Ofi ce of Science and Technology, Engineering and Analysis Division.